MAP Format for Representing Chemical Modifications, Annotations, and Mutations in Protein Sequences: An Extension of the FASTA Format

TL;DR

The paper introduces MAP, a new comprehensive format for representing detailed chemical modifications, annotations, and mutations in protein sequences, extending the capabilities of FASTA for bioinformatics applications.

Contribution

It proposes the MAP format with meta tags and inline annotations to better represent complex protein modifications and variants, addressing limitations of existing formats.

Findings

MAP enables detailed annotation of protein modifications.

It supports residue-specific features like phosphorylation and non-natural residues.

The format is demonstrated in bioinformatics and protein therapeutics contexts.

Abstract

Several formats, including FASTA, PIR, GenBank, EMBL, and GCG, have been developed for representing protein sequences composed of natural amino acids. Among these, FASTA remains the most widely used due to its simplicity and human readability. However, FASTA lacks the capability to represent chemically modified or non-natural residues, as well as structural annotations and mutations in protein variants. To address some of these limitations, the PEFF format was recently introduced as an extension of FASTA. Additionally, formats such as HELM and BILN have been proposed to represent amino acids and their modifications at the atomic level. Despite their advancements, these formats have not achieved widespread adoption within the bioinformatics community due to their complexity. To complement existing formats and overcome current challenges, we propose a new format called MAP (Modification and Annotation in Proteins), which enables comprehensive annotation of protein sequences. MAP introduces meta tags in the header for protein-level annotations and inline tags within the sequence for residue-level modifications. In this format, standard one-letter amino acid codes are augmented with curly-brace tags to denote various modifications, including phosphorylation, acetylation, non-natural residues, cyclization, and other residue-specific features. The header metadata also captures information such as organism, function, and sequence variants. We describe the structure, objectives, and capabilities of the MAP format and demonstrate its application in bioinformatics, particularly in the domain of protein therapeutics. To facilitate community adoption, we are developing a comprehensive suite of MAP-format resources, including a detailed manual, annotated datasets, and conversion tools, available at http://webs.iiitd.edu.in/raghava/maprepo/.